Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer
The efficacy of chemotherapy varies significantly among patients with gastric cancer (GC), and there is currently no effective strategy to predict chemotherapeutic outcomes. In this study, we successfully establish 57 GC patient-derived organoids (PDOs) from 73 patients with GC (78%). These organoid...
Saved in:
Main Authors: | Zhao, Yi, Li, Shangru, Zhu, Lefan, Huang, Mingle, Xie, Yubin, Song, Xinming, Chen, Zhihui, Lau, Harry Cheuk-Hay, Sung, Joseph Jao Yiu, Xu, Lixia, Yu, Jun, Li, Xiaoxing |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/181601 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
by: Chan D.Y.S., et al.
Published: (2018) -
Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2011) -
Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan
by: Kono K., et al.
Published: (2018) -
Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
by: Yan, B., et al.
Published: (2014) -
Protein profiling of human gastric fluid and gastric cancer biomarker discovery.
by: LAI LIYUN
Published: (2014)